HomeCompaniesProfile

AOA Dx

Blood Test for Early Detection of Ovarian Cancer  


Company Size

11 - 50 employees

Year Founded

2020


About AOA Dx

AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.

Founders & Key People

Oriana Papin-Zoghbi

Oriana Papin-Zoghbi

Founder, AOA Dx

Alex Fisher

Alex Fisher

Founder/COO, AOA Dx

Anna Jeter

Anna Jeter

Founder, AOA Dx

Share This Profile

More Companies

CodeCrafters

Programming courses for experienced engineers

Rubber Ducky Labs

AI Powered Product Discovery

Datadog

Cloud-scale monitoring and security for metrics, traces and logs in one unified platform.

Foundersuite

Software for raising capital and managing investors.

Notion

The connected workspace for your docs, projects, and knowledge.

Nephrogen

Curative gene therapies for kidney diseases

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.